For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241010:nRSJ7653Ha&default-theme=true
RNS Number : 7653H THG PLC 10 October 2024
10 October 2024
THG PLC
Third quarter trading statement for the period ended 30 September 2024
Continuing Q3 revenue of £433.1m (-0.6% CCY)
Growth in Beauty and Ingenuity with improving trends in Nutrition through the
quarter
Full-year performance expected to be within the company consensus range
Submission of THG's notification to the FCA for inclusion in the Equity Shares
(Commercial Companies) ("ESCC") category
Q3 2024 Group Trading Performance
£m Q3 YoY 1 CCY 2 YTD YoY CCY
2024
change
change
2024 change change
THG Beauty 254.7 +2.3% +2.8% 775.0 +5.2% +7.3%
THG Nutrition 134.5 -13.1% -10.5% 434.3 -11.6% -7.4%
THG Ingenuity (external) 44.0 +15.0% +16.0% 124.2 +13.5% +16.0%
Group (continuing) revenue 433.1 -2.0% -0.6% 1,333.5 -0.3% +2.7%
Discontinued revenue 9.7 -61.3% -61.0% 43.3 -56.2% -55.3%
Total revenue 442.8 -5.2% -3.9% 1,376.8 -4.1% -1.3%
THG Ingenuity (internal) 98.9 -15.7% -15.7% 324.6 -11.4% -11.4%
THG Ingenuity total 142.9 -8.2% -8.0% 448.7 -5.7% -5.2%
All comparative figures are continuing CCY unless otherwise stated.
· Continued growth in THG Beauty and THG Ingenuity (external), with
improving trends in THG Nutrition during the quarter.
· Solid performance in THG Beauty as it builds to peak trading with
advent calendar order run rate materially higher YoY.
o Performance in the UK (over half of online Beauty revenue) was notably
strong with active customers in growth (+5%).
o Lookfantastic also launched its first flagship retail store as part of its
targeted omnichannel strategy to enhance brand awareness, customer appeal and
aid product discovery.
· Nutrition YoY revenue performance improved each month through the
quarter.
o Sales have recovered from July and improved steadily through the quarter
as the effect from the Myprotein rebrand fades, with September marking the
second-best sales performance of the year, finishing the month in online
growth excluding Asia.
o Offline revenue growth of +17% in the quarter supports our expectations of
c.25% of total brand sales coming from offline channels over the medium-term.
o The transitionary impact from the rebrand is now behind Myprotein.
o Licencing highlights include the launch of co-branded Müller dairy
products in major UK and Ireland supermarkets in September, with a complete
nutrition ready-to-drink product also available later this month.
· THG Ingenuity external revenue growth driven by existing and new
partnerships mainly within fulfilment and courier management services.
o Monthly recurring revenue 3 for THG Ingenuity (external) continued to
build in September at +44.9% YoY, an acceleration on September 2023 (+7.6%
YoY).
o Onboarding of CDS Superstores (trading as wilko and The Range) and MySale
complete with first dispatches in the quarter. Delivery options have already
been expanded for both clients enhancing their customer proposition.
o Fulfilment efficiency is expected to improve further for peak trading this
year with the addition of Goods-To-Person robotics at the Group's Omega
distribution centre enabling faster dispatch times.
· As part of the Group's ongoing portfolio management to further
streamline all three businesses and optimise margin and cash generation,
certain THG Beauty territories and non-core services were discontinued during
Q3. Please refer to the appendix for the previous quarter comparatives.
ESCC transfer
· The Company's initial notification and eligibility letter for
transfer to the ESCC category has been submitted to the FCA (1(st) October
2024). The Company continues to target effecting the transfer this calendar
year and to be included in the FTSE UK Index reclassification in March 2025.
Outlook and guidance
· As noted in THG's Interim Results published on 17 September 2024,
the second half of the year remains the Group's most profitable and cash
generative period with the Board expecting full-year performance to be within
the company consensus range 4 .
· Seasonal weighting and continued revenue growth in Beauty and
Ingenuity gives us confidence in the outturn, albeit we continue to monitor FX
movements (Japanese Yen c.£7m ytd impact) and rising whey prices.
Matthew Moulding, CEO of THG commented:
"Today we have separately announced significant progress on our strategy to
demerge THG Ingenuity into a private company supported by major shareholders.
THG PLC will remain a listed leading consumer brands group, with our planned
transfer to the ESCC well on track.
"It was especially pleasing to see another solid quarter of delivery from both
our Beauty and Ingenuity businesses, rewarding the significant overhaul of
their respective operating models during 2022 and 2023. The short-term
disruption from the major rebrand of Myprotein is now behind us, and we were
pleased that in September Nutrition delivered its best sales performance since
January.
"We are also proud to be recognised in the top 250 companies worldwide for our
contribution and efforts in sustainability thanks to our ongoing progress
towards our net zero goals.
"Preparations for our busiest trading period are well advanced with
efficiencies across the network over the last twelve months delivering further
benefits for our Ingenuity clients to aid new customer acquisition."
Analyst and Institutional investor conference call
THG will host a conference call for analysts and institutional investors at
9:30am 11(th) of October (UK time) via the following link:
https://stream.brrmedia.co.uk/broadcast/67068e9c5c401b3f38830f49
(https://stream.brrmedia.co.uk/broadcast/67068e9c5c401b3f38830f49)
To ask questions, you must dial in via conference line using the below
details:
· Confirmation password: THG Q3
· UK dial in: +44 (0) 33 0551 0200
· US dial in: +1 786 697 3501
For further information please contact:
Investor enquiries - THG PLC
Greg Feehely, SVP Investor Relations Investor.Relations@thg.com (mailto:Investor.Relations@thg.com)
Kate Grimoldby, Director of Investor Relations and Strategic Projects
Media enquiries:
Sodali & Co - Financial PR adviser Tel: +44 (0) 20 7250 1446
Victoria Palmer-Moore / Russ Lynch thg@sodali.com (mailto:thg@powerscourt-group.com)
THG PLC
Viki Tahmasebi Viki.tahmasebi@thg.com (mailto:Viki.tahmasebi@thg.com)
APPENDIX
Quarterly reported revenue growth rates
Q1 2023 Q2 2023 Q3 2023 Q4 2023 FY 2023 Q1 2024 Q2 2024 Q3 2024 YTD 2024
THG Beauty -9.8% -8.3% -1.6% +1.4% -4.1% +11.4% +2.6% +2.3% +5.2%
THG Nutrition +5.7% +1.8% -3.8% -6.0% -0.7% -9.0% -12.8% -13.1% -11.6%
THG Ingenuity -14.3% -15.4% -8.8% -5.8% -11.0% -5.3% -3.6% -8.2% -5.7%
Inter-group elimination -15.5% -17.1% -10.5% -9.0% -13.0% -8.0% 10.6% -15.7% -11.4%
Group (continuing) revenue -4.4% -4.9% -2.5% -0.5% -2.9% +2.9% -1.6% -2.0% -0.3%
Other (discontinued) -38.1% -48.5% -60.1% -53.0% -50.0% -54.8% 54.1% -61.3% -56.2%
Group revenue -8.3% -10.3% -9.5% -6.9% -8.7% -2.0% -5.2% -5.2% -4.1%
Memo: External Ingenuity -10.1% -8.6% -2.9% +7.1% -3.5% +4.1% +21.2% +15.0% +13.5%
Quarterly constant currency revenue growth rates
Q1 2023 Q2 2023 Q3 2023 Q4 2023 FY 2023 Q1 2024 Q2 2024 Q3 2024 YTD 2024
THG Beauty -12.9% -8.5% 0.9% +3.2% -3.9% +13.2% +3.2% +2.8% +7.3%
THG Nutrition +3.8% +2.0% -1.4% -4.0% 0.0% -5.8% -9.2% -10.5% -7.4%
THG Ingenuity -14.7% -15.4% -8.5% -5.4% -10.9% -4.9% -3.5% -8.0% -5.2%
Inter-group elimination -15.5% -17.1% -10.5% -9.0% -13.0% -8.0% -10.6% -15.7% -11.4%
Group (continuing) revenue -7.1% -5.0% -0.1% +1.5% -2.5% +5.3% +0.2% -0.6% +2.7%
Other (discontinued) -37.7% -48.5% -59.9% -52.9% -49.9% -53.9% -53.7% -61.0% -55.3%
Group revenue -11.0% -10.1% -7.6% -5.3% -8.4% +0.3% -3.4% -3.9% -1.3%
Memo: External Ingenuity -11.7% -8.8% -1.4% +9.4% -3.1% +5.9% +22.3% +16.0% +16.0%
Quarterly reported revenue
£m Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 YTD
2023 2023 2023 2023 2023 2024 2024 2024 2024
THG Beauty 227.9 259.6 249.0 360.3 1,096.9 253.9 266.3 254.7 775.0
THG Nutrition 165.7 171.0 154.8 166.4 657.9 150.8 149.0 134.5 434.3
THG Ingenuity (external) 35.6 35.6 38.2 44.6 154.0 37.0 43.2 44.0 124.2
Group (continuing) revenue 429.2 466.2 442.1 571.4 1,908.9 441.8 458.6 433.1 1,333.5
Discontinued revenue 40.1 33.7 25.0 37.6 136.5 18.2 15.5 9.7 43.3
Total revenue 469.4 499.9 467.2 609.0 2,045.4 459.9 474.0 442.8 1,376.8
THG Ingenuity (internal) 122.3 126.5 117.4 153.6 519.9 112.6 113.0 98.9 324.6
THG Ingenuity total 157.9 162.1 155.7 198.2 673.9 149.6 156.2 142.9 448.7
Quarterly constant currency revenue growth rates
Q1 2023 Q2 2023 Q3 2023 Q4 2023 FY 2023 Q1 2024 Q2 2024 Q3 2024 YTD 2024
THG Beauty -12.9% -8.5% 0.9% +3.2% -3.9% +13.2% +3.2% +2.8% +7.3%
THG Nutrition +3.8% +2.0% -1.4% -4.0% 0.0% -5.8% -9.2% -10.5% -7.4%
THG Ingenuity -14.7% -15.4% -8.5% -5.4% -10.9% -4.9% -3.5% -8.0% -5.2%
Inter-group elimination -15.5% -17.1% -10.5% -9.0% -13.0% -8.0% -10.6% -15.7% -11.4%
Group (continuing) revenue -7.1% -5.0% -0.1% +1.5% -2.5% +5.3% +0.2% -0.6% +2.7%
Other (discontinued) -37.7% -48.5% -59.9% -52.9% -49.9% -53.9% -53.7% -61.0% -55.3%
Group revenue -11.0% -10.1% -7.6% -5.3% -8.4% +0.3% -3.4% -3.9% -1.3%
Memo: External Ingenuity -11.7% -8.8% -1.4% +9.4% -3.1% +5.9% +22.3% +16.0% +16.0%
Quarterly reported revenue
£m Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 YTD
2023 2023 2023 2023 2023 2024 2024 2024 2024
THG Beauty 227.9 259.6 249.0 360.3 1,096.9 253.9 266.3 254.7 775.0
THG Nutrition 165.7 171.0 154.8 166.4 657.9 150.8 149.0 134.5 434.3
THG Ingenuity (external) 35.6 35.6 38.2 44.6 154.0 37.0 43.2 44.0 124.2
Group (continuing) revenue 429.2 466.2 442.1 571.4 1,908.9 441.8 458.6 433.1 1,333.5
Discontinued revenue 40.1 33.7 25.0 37.6 136.5 18.2 15.5 9.7 43.3
Total revenue 469.4 499.9 467.2 609.0 2,045.4 459.9 474.0 442.8 1,376.8
THG Ingenuity (internal) 122.3 126.5 117.4 153.6 519.9 112.6 113.0 98.9 324.6
THG Ingenuity total 157.9 162.1 155.7 198.2 673.9 149.6 156.2 142.9 448.7
Above numbers and table subject to rounding.
ENDS
Notes to editors
THG PLC operate three distinct businesses in Beauty, Nutrition and Ingenuity,
each scaled from the UK to hold global leading positions in their respective
sectors.
Cautionary Statement
Certain statements included within this announcement may constitute
"forward-looking statements" in respect of the group's operations,
performance, prospects and/or financial condition. Forward-looking statements
are sometimes, but not always, identified by their use of a date in the future
or such words and words of similar meaning as "anticipates", "aims", "due",
"could", "may", "will", "should", "expects", "believes", "intends", "plans",
"potential", "targets", "goal" or "estimates". By their nature,
forward-looking statements involve a number of risks, uncertainties and
assumptions and actual results or events may differ materially from those
expressed or implied by those statements. Accordingly, no assurance can be
given that any particular expectation will be met and reliance should not be
placed on any forward-looking statement. Additionally, forward-looking
statements regarding past trends or activities should not be taken as a
representation that such trends or activities will continue in the future. No
responsibility or obligation is accepted to update or revise any
forward-looking statement resulting from new information, future events or
otherwise. Nothing in this announcement should be construed as a profit
forecast. This announcement does not constitute or form part of any offer or
invitation to sell, or any solicitation of any offer to purchase any shares or
other securities in the Company, nor shall it or any part of it or the fact of
its distribution form the basis of, or be relied on in connection with, any
contract or commitment or investment decisions relating thereto, nor does it
constitute a recommendation regarding the shares or other securities of the
Company. Past performance cannot be relied upon as a guide to future
performance and persons needing advice should consult an independent financial
adviser. Statements in this announcement reflect the knowledge and information
available at the time of its preparation.
1 YoY defined as year-on-year statutory sales growth
(( 2 )) CCY defined as constant currency basis
3 Monthly Recurring Revenue comprises Software-as-a-Service license fees,
managed service fees, revenue share, fulfilment and creative services
4 Adjusted EBITDA range of £124.4m to £141.0m as dated 07.10.24 and
available at Analyst Consensus - THG.com
(https://www.thg.com/investor-relations/analyst-consensus)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TSTEBLFFZBLXFBK